Treatment of Parkinson's disease.
McFarland
H R
HR
D000978:Antiparkinson Agents / Q000191:economics / Q000627:therapeutic use; D003365:Costs and Cost Analysis; D003704:Dementia / Q000150:complications; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy / Q000191:economics / Q000628:therapy*; D026741:Physical Therapy Modalities; D012642:Selegiline / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use
D000978:Antiparkinson Agents; D012642:Selegiline